¡°	crude ISB	22.228482862350994
¡°	ISB compound	21.551014852115486
¡°	ISB sale	21.507173640119237
¡°	ISB manufacture	21.506343488703354
¡°	ISB purity	15.686338078395886
	ANDA application	12.830486564000346
	obviousness argument	12.80538071640047
¡°	less pure ISB	10.814314021780664
¡°	isosulfan blue ISB product	8.093969034868879
¡°	high purity ISB	7.843316695768785
¡°	ISB drug product	7.179554888131361
¡°	entire ISB business	7.1734893867146745
	preparatory HPLC	7.024989126671914
	revenue	6.711824391251592
	US LLC	5.75167533868428
	patented process	5.004314931383362
	FWR	4.82700957959891
	manganese dioxide process	4.701839112896323
	silver oxide	4.60239636141189
	specific HPLC parameter	4.561144379299168
	isoleuco acid	3.311132715641113
	HPLC limitation	2.2721594638476144
	Lymphazurin (r) production	2.0075621990862693
¡°	isosulfan blue acid	1.8964392108923904
	accuse isosulfan	1.44309669845593
	Recommendation	1.4324384289177334
	ultimate purity	1.3494165793669974
	different purity	1.3491962318517163
	oxidation strength	1.166314940180995
	Hirsch Industries	1.046403927177703
	thus purity	1.011869680915415
	Innovassynth product	0.9628466696622939
	Violet Blue	0.8970691153319532
	recrystallization	0.7230235134792725
	Apicore3	0.7230235134792725
	lymph node	0.570041296401703
	Lot	0.4818101838735603
	ammonium dichromate	0.4716708681772991
	Institutional LLC Inst	0.4615272451792841
	synthesis	0.4310130383049176
	Hirsch original clinical trial	0.42051899717071717
	Nat	0.41705907932413333
	several blue dye compound	0.400303338694563
	expert testimony	0.3869315261499035
	substantially strong oxidizing agent	0.3586564532860349
	irreparable harm	0.33995486018617255
	triarylmethane dye	0.33682938089136266
	mild oxidant	0.31444724545153274
	Certificate	0.31133814948605526
	polar solvent	0.29805544644924875
	residual chromium impurity	0.293239363478303
	causal nexus	0.2888281298904062
	Auromedics Pharma LLC	0.26532045539643606
	district court2	0.241007846300573
	manufacturing process	0.22626600092500748
	preliminary injunction	0.21275500895895283
	sole supplier	0.2094613512737228
	equivalence	0.20932059186193713
	Report	0.20307277515843325
	purify compound	0.2016566914242254
	Amazon.com	0.19649350113679387
	purified compound	0.19090987419807304
	AMF	0.17519438191596015
	sodium salt	0.15193018978336303
	inception	0.14536419800867312
	Def	0.14379368621656538
	Robert Schroeder III	0.14342582776386373
	recommendation	0.1375577928577361
	Analysis	0.12085733543114546
	praise	0.10934712608260122
	high performance liquid chromatography	0.10633909860119298
	preliminary relief	0.10543664585535154
	Ry	0.1030709133378099
	exclusionary right	0.09696557394234377
	Council Inc.	0.09690946533911542
	sanofi Synthelabo	0.09637549563268005
	sodium solution	0.09296244049815133
	E.D. Tex	0.09228185788111544
	successor	0.0891434241538666
	Order	0.0763434064643962
	equity	0.07098332335086888
	process patents]. Idaho	0.06967256503056725
	closely related isomer	0.06448572765612795
	lot number	0.06050301282464047
	four hallmark example	0.0551332295348927
	injectable solution	0.05352663215904502
	copying	0.04959384791137803
	unwanted lead	0.04818522430825025
	bargain	0.04793122873885513
	indefiniteness	0.04440905486469144
	ongoing research	0.04384257061172405
	lower price pharmaceutical compound	0.03943479923994717
	reaction	0.03552194467790993
	I. Process Patents	0.03209878991090405
	safety	0.03074096541383764
	lead compound	0.03041860518635697
	scientific literature	0.030232973853704038
	effectiveness	0.02401548507788839
	internal quotation mark	0.023027085786893175
	difficulty	0.02294192121548582
	similar yield	0.021674171377651007
	insubstantial difference test	0.021245816999128704
	prior art mixture	0.02050917512631946
	Barnesandnoble.com Inc.	0.020385227260567938
	initial sample preparation	0.020068798972063658
	Lourie	0.018335457076536138
	prima facie	0.01739047481273885
	Food Drug Administration FDA approval	0.017196326671171856
	equivalent	0.015880760270226533
	Texas	0.015301140079573913
	exclusive licensee	0.014725812420014998
	abbreviate drug application	0.014692455410773436
	customer	0.014621615712065685
	reasonable expectation	0.013764986402528562
	GmbH	0.010386143453058426
	trade name	0.00956917772348595
	isolation process	0.008993606708141505
	Apotex	0.007653836722523794
	unexpected result	0.0072229274889547305
	numerous problem	0.00669761297517708
	patentable weight	0.006322627129252479
	WL	0.005864666098413625
	numerous source	0.00527950242918068
	motivation	0.0051169543276016775
	original drug application	0.004906638386913563
	sound discretion	0.004510074116989839
	skilled artisan	0.004244768537801231
	predecessor	0.003826918361261897
	commercial success	0.003701585855338081
	development	0.0030873633389709603
	secondary consideration	0.0029622062610061644
	generic version	0.0029068617634683967
	public interest factor	0.002742990642521607
	Eastern District	0.0023365831427787456
	substantial question	0.0020940853360448867
	continue infringement	0.0017008872025088696
	document	0.0010375581010575472
	denial	0.0008104678888860268
	improve process	0.0007649105494978535
	function way result	0.0007561778929445347
	relevant factor	0.0006987155632638043
	validity	0.0006519513133149562
	plaintiff	0.00042176850064820187
	face	0.00032922000214751017
	different structure	0.0002731565667670007
	common well understand way	0.00024258031859006836
	significant portion	0.0002327624221822855
	clearly erroneous factual finding	0.00019892961966753032
	analysis	0.00015064682191212668
	Ltd.	0.0001273627202629464
	certain product number	0.00012391889709669954
	favor	0.00011794843453671284
	method	7.736283185419105e-05
	lack	7.59110906566178e-05
	various combination	7.524634514658013e-05
	background	6.937326951648979e-05
	different result	6.562464566274852e-05
	emphasis	5.955764067624136e-05
	clear error	5.502837681295495e-05
	turn	5.481025680839153e-05
	holding	3.565538847473538e-05
	Claim	3.3179168586434765e-05
	jurisdiction	2.942134316502121e-05
	read	2.6336894589291313e-05
	law de novo	2.4301504593830542e-05
	position	2.2860207945145798e-05
	need	1.651061471385318e-05
	court finding	1.0467593228764744e-05
	patentee	5.157554658801029e-06
	Int'l Inc.	5.1295730410719376e-06
	order	3.820612923502779e-06
	record evidence	3.256149401678595e-06
	J.	2.2080944555232686e-06
	light	1.7864670528993596e-06
	district court grant	1.7662805596655394e-06
	district court conclusion	5.93948342455485e-07
	reference	4.559329231878088e-07
	assert	1.5153598782000833e-07
	invention	1.2437224030826214e-09
	judgment	9.335877001404997e-10
	Court	0.0
	Appeals	0.0
	Fed	0.0
